Gilead Sciences (GILD) Shares Outstanding (Weighted Average) (2009 - 2026)

Gilead Sciences (GILD) has 18 years of Shares Outstanding (Weighted Average) data on file, last reported at $1.2 billion in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) changed 0.32% year-over-year to $1.2 billion; the trailing twelve-month figure through Mar 2026 stood at $1.2 billion (changed 0.32% YoY), and the FY2025 full-year result was $1.2 billion, changed 0.24% from the prior year.
• Shares Outstanding (Weighted Average) for Q1 2026 stood at $1.2 billion, roughly flat from $1.2 billion in the prior quarter.
• Across five years, Shares Outstanding (Weighted Average) topped out at $1.3 billion in Q1 2022 and bottomed at $1.2 billion in Q1 2026.
• The 5-year median for Shares Outstanding (Weighted Average) is $1.2 billion (2024), against an average of $1.2 billion.
• The widest annual swing landed in 2022, when Shares Outstanding (Weighted Average) retreated 0.08%; it then decreased 0.56% in 2023.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $1.3 billion in 2022, then slipped by 0.56% to $1.2 billion in 2023, then fell by 0.08% to $1.2 billion in 2024, then declined by 0.24% to $1.2 billion in 2025, then slipped by 0.16% to $1.2 billion in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $1.2 billion (Q1 2026), $1.2 billion (Q4 2025), and $1.2 billion (Q3 2025), per Business Quant data.

Peer Comparison